BioMed Realty Trust Inc Stock Downgraded (BMR)

NEW YORK (TheStreet) -- BioMed Realty (NYSE:BMR) has been downgraded by TheStreet Ratings from buy to hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins.

Highlights from the ratings report include:

• Despite its growing revenue, the company underperformed as compared with the industry average of 19.2%. Since the same quarter one year prior, revenues rose by 14.1%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
• The debt-to-equity ratio is somewhat low, currently at 0.71, and is less than that of the industry average, implying that there has been a relatively successful effort in the management of debt levels.
• BIOMED REALTY TRUST INC's earnings per share declined by 50.0% in the most recent quarter compared to the same quarter a year ago. Stable earnings per share over the past year indicate the company has sound management over its earnings and share float. However, the consensus estimates suggest that there will be an upward trend in the coming year. During the past fiscal year, BIOMED REALTY TRUST INC's EPS of $0.18 remained unchanged from the prior years' EPS of $0.18. This year, the market expects an improvement in earnings ($0.28 versus $0.18).
• The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. Compared to other companies in the Real Estate Investment Trusts (REITs) industry and the overall market on the basis of return on equity, BIOMED REALTY TRUST INC underperformed against that of the industry average and is significantly less than that of the S&P 500.
• The gross profit margin for BIOMED REALTY TRUST INC is rather low; currently it is at 24.00%. It has decreased from the same quarter the previous year. Along with this, the net profit margin of 1.90% significantly trails the industry average.

.

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. The company has a P/E ratio of 104.3, equal to the average real estate industry P/E ratio and above the S&P 500 P/E ratio of 17.7. BioMed has a market cap of $3.06 billion and is part of the financial sector and real estate industry. Shares are up 11.7% year to date as of the close of trading on Wednesday.

You can view the full BioMed Ratings Report or get investment ideas from our investment research center.
-- Written by a member of TheStreet Ratings Staff

For more information on BioMed Realty Trust Inc click any of the following:

• BioMed Realty Trust Inc Stock Price

• BioMed Realty Trust Inc Analyst Ratings

• BioMed Realty Trust Inc Key Stats & Profile

• BioMed Realty Trust Inc Earnings

• BioMed Realty Trust Inc Ratio Comparison

• BioMed Realty Trust Inc Growth Rates

• BioMed Realty Trust Inc Balance Sheet

• BioMed Realty Trust Inc Cash Flow

• BioMed Realty Trust Inc Income Statement